Chargement en cours...
Simultaneous blocking of the pan‐RAF and S100B pathways as a synergistic therapeutic strategy against malignant melanoma
Melanoma is a very aggressive form of skin cancer. Although BRAF inhibitors have been utilized for melanoma therapy, advanced melanoma patients still face a low five‐year survival rate. Recent studies have shown that CRAF can compensate for BRAF depletion via regulating DNA synthesis to remain melan...
Enregistré dans:
| Publié dans: | J Cell Mol Med |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7882986/ https://ncbi.nlm.nih.gov/pubmed/33377602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15994 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|